ACTRN12605000322639已完成2 期
A pilot Open Label Study of Aripiprazole as Add On Therapy in Post Traumatic Stress disorder as measured by impact on CAPS-2 scores
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •PTSD according to DSM-IV criteria and a baseline CAPS 2 score greater than 50.
排除标准
- •Current substance use disorder.
研究者
相似试验
已完成
不适用
Efficacy of aripiprazole in the treatment of autismAutistic disorder.Chilhood autismIRCT201209309645N2niversity of Social Welfare and Rehabilitation Sciences5
未知
4 期
Post Marketing Clinical Study of Aripiprazole in Patients with Schizophrenia - Effects on Glucose MetabolismSchizophreniaJPRN-jRCT1080220320Otsuka Pharmaceutical Co., Ltd.
已完成
2 期
Effect of aripiprazole on prevention of deleriumIRCT2017011810178N12Shahid Beheshti University of Medical Science40
已完成
3 期
VERBATIM: A randomised controlled trial of aripiprazole for the treatment of auditory verbal hallucinations in borderline personality disorderBorderline personality disorderACTRN12616001192471Orygen78
未知
3 期
ong-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients with Major Depressive DisorderMajor Depressive DisorderJPRN-jRCT2080220699Otsuka Pharmaceutical Co., Ltd.100